Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Mar;56(1):186-92.
doi: 10.1097/GRF.0b013e31827feea4.

Neonatal abstinence syndrome: treatment and pediatric outcomes

Beth A Logan  1 , Mark S Brown, Marie J Hayes
Affiliations
Review

Neonatal abstinence syndrome: treatment and pediatric outcomes

Beth A Logan et al. Clin Obstet Gynecol. 2013 Mar.

Abstract

Recent rise in rates of opiate replacement therapy among pregnant women have resulted in increasing number of infants requiring treatment for neonatal abstinence syndrome (NAS). Short-term and long-term developmental outcomes associated with prenatal opiate exposure are discussed, including symptoms and severity of NAS, and early cognitive and motor delays. Maternal and infant risk factors are discussed, and include patterns of maternal substance use during pregnancy, genetic risk, polysubstance exposure pharmacological treatment for NAS and breastfeeding. The importance of characterizing corollary environmental risk factors is also considered.

PubMed Disclaimer

References

    1. NSDUH. National Survey on Drug Use and Health: National Findings. 2008
    1. TEDS; DHHS, OSA. Treatment Episode Data Set (TEDS) 2007.
    1. Finnegan LP, Hagan T, Kaltenbach KA. Scientific foundation of clinical practice: opiate use in pregnant women. Bull N Y Acad Med. 1991;67(3):223–239. - PMC - PubMed
    1. Oei J, Lui K. Management of the newborn infant affected by maternal opiates and other drugs of dependency. Journal of Paediatrics and Child Health. 2007;43(1–2):9–18. - PubMed
    1. McCarthy JJ. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: Can we assure the safety of the fetus? J Matern-Fetal Neo M. 2012;25(2):109–112. - PubMed

Publication types

MeSH terms